As DNMT3B levels are very low in adult muscle tissue (0.4 to 0.5 TPM), we were unable to confidently call differential splicing of DNMT3B from the FSHD patients’ single-end RNA-seq data. The gene discussed is DNMT3B; the disease is facioscapulohumeral muscular dystrophy.